Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

PepsiCo to spend $322.96 million on sports sponsorship deals in Americas for 2023, estimates GlobalData

Over 110 non-alcoholic beverage brands, which include many globally recognised brands, have active sponsorship deals in place with sports properties based mainly in the US. Many of these deals are title or main sponsorship deals, which allow brands to receive substantial brand exposure opportunities, often from sports properties that have substantial global fanbases. With many […]
Read more

China’s CAR-T cell therapy advancements still need to garner more attention from big pharma, says GlobalData

Chimeric Antigen Receptor- T (CAR-T) cell therapy, a revolutionary approach to treating certain types of cancer, has gained significant attention globally for its potential to transform cancer treatment paradigms. Although Western pharmaceutical companies were the first to develop CAR-T therapies, China has become a major force in the advancement of this innovative field in recent […]
Read more

Diagnosed prevalent cases of NASH to reach 26.55 million in 7MM by 2032, estimates GlobalData

The diagnosed prevalent cases of non-alcoholic steatohepatitis (NASH/MASH) in the seven major markets (7MM*) are projected to increase from 22.04 million in 2022 to 26.55 million in 2032, registering an annual growth rate (AGR) of 2.05%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report: ‘Non-Alcoholic Steatohepatitis (NASH/MASH): Epidemiology Forecast to 2032’ […]
Read more

Red Bull to top sports sponsorship spending in EMEA in 2023, says GlobalData

Over 270 non-alcoholic beverage brands, which include many globally recognised brands, have active sponsorship deals in place with sports properties based mainly across Europe, as of October 2023. Many of these deals are highly lucrative, with seven non-alcoholic beverage brand deals worth over $5 million annually. Among these brands, Red Bull is the biggest spending […]
Read more

UEFA Champions League to generate $606.33 million in sponsorship revenue for 2023-24 season, reveals GlobalData

Sponsorship plays a crucial role in supporting the Union of European Football Associations (UEFA) in maintaining its ambition of hosting the best professional soccer tournaments in the world, including the Champions League, Europa League, and Europa Conference League. It contributes to the smooth operation of each competition, as exemplified by its top associations with Heineken, […]
Read more

Non-alcoholic beverage brands generate $83.09 million in sports sponsorship revenue in APAC for 2023, reveals GlobalData

Sponsorship plays a crucial role in supporting sports properties around the APAC region, in maintaining their operations, and in improving their regional and global exposure. It contributes to the enhancement of sports in the region and increases exposure to those brands likewise. Overall, 179 non-alcoholic beverage brands engaged in sports sponsorship within APAC in 2023, […]
Read more

UK telecoms challengers play vital role in driving competition in B2B market, says GlobalData

In a UK telecoms market challengers report, the wide range of providers highlighted across the value chain (covering networks to managed services) signifies a dynamic and highly competitive market when selling to businesses, finds analysis by GlobalData, a leading data and analytics company. Robert Pritchard, Principal Analyst at GlobalData, says: “It is remarkable how much […]
Read more

AstraZeneca’s oral GLP-1 combination for obesity and comorbidities to face increasingly competitive market, says GlobalData

AstraZeneca recently announced its strategy for the cardiometabolic market, in particular treating obesity and its comorbidities, by combining the glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy that the company recently acquired from Eccogene (ECC5004) with its cardio-metabolic therapies such as sodium-glucose co-transporter-2 (SGLT2) inhibitor Farxiga (dapagliflozin). The company intends to combine ECC5004 with treatments in its […]
Read more

World AMR Awareness Week 2023: Investment in novel therapies key priority, says GlobalData

World AMR Awareness Week (WAAW)* is observed on 18-24 November every year with the aim of improving awareness and understanding of antimicrobial resistance (AMR) and encouraging best practices for the responsible usage of antimicrobials. This year’s theme “Preventing antimicrobial resistance together” highlights the importance of cross-sectoral collaboration for tackling AMR. It serves as an important […]
Read more

Home-based medical devices will bring fundamental change in elderly healthcare landscape, says GlobalData

The demand for home-based medical devices is driven by an aging population, advancements in technology, and the global shift towards personalized healthcare. From glucose monitors for diabetics to wearable ECG monitors for cardiac patients, the diversity of offerings is expanding rapidly. These devices will fundamentally alter the healthcare landscape of the elderly and play a […]
Read more

Modernization initiatives to drive Brazil’s defense budget to reach $29.9 billion by 2028, forecasts GlobalData

The growing need to protect its borders, the Amazon rainforest, and substantial offshore oil discoveries has compelled the Brazilian government to invest significantly in defense projects. As a result, the Brazilian Army has many ongoing and planned projects under its modernization plans.  Against this backdrop, its defense expenditure is expected to increase steadily, reaching a […]
Read more

Novo Nordisk targets to affirm superiority of CagriSema in obesity market, says GlobalData

Eli Lilly recently received FDA approval for Zepbound (tirzepatide), its glucagon-like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) dual agonist for patients with obesity. In response to Zepbound’s approval, Novo Nordisk launched a Phase III trial with the aim of proving the superiority of its pipeline combination therapy CagriSema as a weight loss drug over its active comparator, […]
Read more
1 … 93 94 95 96 97 … 136